ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,827.04
      -1.54%
      US Tech 100
      20,287.60
      0.00%
      Dow Jones
      41,938.45
      -1.63%
      Brent Oil
      80.435
      -0.22%
      Bitcoin
      93,396.01
      -1.16%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Siauliu Bankas Ab (0KC0) Quote

      Siauliu Bankas Ab

      Siauliu Bankas Ab (0KC0)

      LSE
      0.504
      0.00
      (0.00%)
      Closed January 13 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.504
      Bid
      0.00
      Ask
      0.00
      Volume
      0.00
      0.00 Day's Range 0.00
      0.504 52 Week Range 0.504
      Market Cap
      334.15M
      Previous Close
      0.504
      Open
      -
      Last Trade
      (O)
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      0.00
      Shares Outstanding
      662,997,000
      Dividend Yield
      -
      PE Ratio
      4.40
      Earnings Per Share (EPS)
      0.11
      Revenue
      184.16M
      Net Profit
      75.38M

      About Siauliu Bankas Ab

      Sector
      Commercial Banks, Nec
      Industry
      Commercial Banks, Nec
      Website
      www.sb.lt
      Headquarters
      Siauliai, Ltu
      Founded
      -
      Siauliu Bankas Ab is listed in the Commercial Banks sector of the London Stock Exchange with ticker 0KC0. The last closing price for Siauliu Bankas Ab was 0.50 €. Over the last year, Siauliu Bankas Ab shares have traded in a share price range of 0.504 € to 0.504 €.

      Siauliu Bankas Ab currently has 662,997,000 shares outstanding. The market capitalization of Siauliu Bankas Ab is 334.15 € million. Siauliu Bankas Ab has a price to earnings ratio (PE ratio) of 4.40.

      Ask ADVFN Intelligence (AI)

      0KC0 Latest News

      More News

      Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 10)

      Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 10) This announcement contains information on transactions of the acquisition of own shares of AB Šiaulių...

      1 hour ago
      UK Regulatory

      Information on shares, voting rights and authorized capital

      Information on shares, voting rights and authorized capital After acquiring its own shares on 07 January 2025, Šiaulių Bankas AB (hereinafter - the Bank) pursuant to Article 19(2) of the Law on...

      January 07 2025
      UK Regulatory

      Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 9)

      Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 9) This announcement contains information on transactions of the acquisition of own shares of AB Šiaulių...

      January 06 2025
      UK Regulatory

      Information on shares, voting rights and authorized capital

      Information on shares, voting rights and authorized capital After acquiring its own shares on 03 January 2025, Šiaulių Bankas AB (hereinafter - the Bank) pursuant to Article 19(2) of the Law on...

      January 03 2025
      UK Regulatory

      Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 8)

      Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 8) This announcement contains information on transactions of the acquisition of own shares of AB Šiaulių...

      December 30 2024
      UK Regulatory

      Information on shares, voting rights and authorized capital

      Information on shares, voting rights and authorized capital After acquiring its own shares on 27 December 2024, Šiaulių Bankas AB (hereinafter - the Bank) pursuant to Article 19(2) of the Law on...

      December 27 2024
      UK Regulatory

      Šiaulių bankas to invest additional €60 million to finance the renovation of multi-apartment buildings in Lithuania

      Šiaulių bankas to invest additional €60 million to finance the renovation of multi-apartment buildings in Lithuania On 20 December, 2024, Šiaulių bankas AB and the European Investment Bank (EIB...

      December 23 2024
      UK Regulatory

      Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 7)

      Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 7) This announcement contains information on transactions of the acquisition of own shares of AB Šiaulių...

      December 23 2024
      UK Regulatory

      Information Release Calendar for 2025

      Information Release Calendar for 2025 In 2025, Šiaulių Bankas will publish information according to the following schedule: 2025-02-26Interim information for the 12 months of...

      December 19 2024
      UK Regulatory

      Information on shares, voting rights and authorized capital

      Information on shares, voting rights and authorized capital After acquiring its own shares on 17 December 2024, Šiaulių Bankas AB (hereinafter - the Bank) pursuant to Article 19(2) of the Law on...

      December 17 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1000.5040.5040.50400DE
      4000.5040.5040.50400DE
      12000.5040.5040.50400DE
      26000.5040.5040.50480.504DE
      52000.5040.5040.50440.504DE
      156000.5040.5040.504350.504DE
      260000.5040.5040.504210.504DE

      0KC0 - Frequently Asked Questions (FAQ)

      What is the current Siauliu Bankas Ab share price?
      The current share price of Siauliu Bankas Ab is 0.504 €
      How many Siauliu Bankas Ab shares are in issue?
      Siauliu Bankas Ab has 662,997,000 shares in issue
      What is the market cap of Siauliu Bankas Ab?
      The market capitalisation of Siauliu Bankas Ab is EUR 334.15M
      What is the 1 year trading range for Siauliu Bankas Ab share price?
      Siauliu Bankas Ab has traded in the range of 0.504 € to 0.504 € during the past year
      What is the PE ratio of Siauliu Bankas Ab?
      The price to earnings ratio of Siauliu Bankas Ab is 4.4
      What is the cash to sales ratio of Siauliu Bankas Ab?
      The cash to sales ratio of Siauliu Bankas Ab is 1.8
      What is the reporting currency for Siauliu Bankas Ab?
      Siauliu Bankas Ab reports financial results in EUR
      What is the latest annual turnover for Siauliu Bankas Ab?
      The latest annual turnover of Siauliu Bankas Ab is EUR 184.16M
      What is the latest annual profit for Siauliu Bankas Ab?
      The latest annual profit of Siauliu Bankas Ab is EUR 75.38M
      What is the registered address of Siauliu Bankas Ab?
      The registered address for Siauliu Bankas Ab is TILZES STR. 149, SIAULIAI, LT-76348
      What is the Siauliu Bankas Ab website address?
      The website address for Siauliu Bankas Ab is www.sb.lt
      Which industry sector does Siauliu Bankas Ab operate in?
      Siauliu Bankas Ab operates in the COMMERCIAL BANKS, NEC sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      0A2IH World Group Ltd
      $ 0.00
      (0.00%)
      		0
      0A2DCrh Plc
      $ 0.00
      (0.00%)
      		0
      0A2BBanco Bilbao Vizcaya Argentaria Sa
      $ 0.00
      (0.00%)
      		0
      0A22Anheuser Busch Inbev Nv
      $ 0.00
      (0.00%)
      		0
      0A1UUber Technologies Inc
      $ 66.00
      (0.00%)
      		1.65k
      0A2IH World Group Ltd
      $ 0.00
      (0.00%)
      		0
      0A2DCrh Plc
      $ 0.00
      (0.00%)
      		0
      0A2BBanco Bilbao Vizcaya Argentaria Sa
      $ 0.00
      (0.00%)
      		0
      0A22Anheuser Busch Inbev Nv
      $ 0.00
      (0.00%)
      		0
      0A1UUber Technologies Inc
      $ 66.00
      (0.00%)
      		1.65k
      0R0XTesla Inc
      $ 388.20
      (0.00%)
      		4.74k
      0JOQJd.com Inc
      $ 72.00
      (0.00%)
      		3.03k
      0HCIAlibaba Group Holding Ltd
      $ 81.10
      (0.00%)
      		2.3k
      0R1OAmazon.com Inc
      $ 217.50
      (0.00%)
      		1.67k
      0P4FFord Motor Co
      $ 9.665
      (0.00%)
      		1.67k

      Discussion

      View Full Feed
      sunspotter sunspotter 10 minutes ago
      Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
      VPLM
      Flobewan Flobewan 21 minutes ago
      Marc loved your ides
      tinojax tinojax 22 minutes ago
      I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
      PLUG
      mrfence mrfence 24 minutes ago
      Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
      [yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
      FMCC FNMA
      IVRT IVRT 41 minutes ago
      In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
      BMXI
      DewDiligence DewDiligence 41 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      ENTA
      DewDiligence DewDiligence 42 minutes ago
      GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

      https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

      Guido2 Guido2 43 minutes ago
      This is DUE DILIGENCE! Thank you Free Fannie.

      https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
      FNMA
      StockItOut StockItOut 49 minutes ago
      That Xeriant PR excellently written with bullshit:

      ""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

      "the Company used the data to make several key
      XERI
      gitreal gitreal 52 minutes ago
      You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
      BMXI
      RichieBoy RichieBoy 58 minutes ago
      Jim wrote a blurb about seeking more US business.

      Help you out any? 🤨
      AFFU
      DesktopDR DesktopDR 59 minutes ago
      Any news or updates?
      VPLM
      Tahoe2468 Tahoe2468 1 hour ago
      .0915 by Thursday....... 
      KRTL
      skitahoe skitahoe 1 hour ago
      Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

      According to Google, GBM ha
      NWBO
      fuagf fuagf 1 hour ago
      You are right about the crafty, evil, smart. Authoritarian methods have been in full view
      in capturing America. While we work to do the right things they plot to capture the lot.
      facts_matter14 facts_matter14 1 hour ago
      If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






      .
      SRMX
      StockItOut StockItOut 1 hour ago
      Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
      XERI
      fuagf fuagf 1 hour ago
      He would smother any question with words.
      Shawonsarker84 Shawonsarker84 1 hour ago
      $HMBL Sorry HMBL investors. XTIA now broke the record 2.7B share volume traded before the reverse split.



      https://x.com/shawonsarker84/status/1878696680088019193?t=rZlhkn2Jos4vWKxxQgXGfA&s=19
      HMBL XTIA
      chen1992 chen1992 1 hour ago
      https://www.energy.senate.gov/hearings/2025/1/hearing-to-consider-the-nomination-of-mr-chris-wright-to-be-secretary-of-energy

      https://www.commerce.senate.gov/2025/1/full-committee-nomination-hearing_2#:~:text=U.S.%20Senator%20Ted%20Cruz%20(R,Wednesday%2C%20January%2015%2C%20
      TGLO
      FNM500K FNM500K 1 hour ago
      Oh noooooo.....
      FNMA
      StockItOut StockItOut 1 hour ago
      OTC filings and attorney statements. my error.

      Point that it is on you to prove your claim, that:
      "There's no contract employees. There's no production shafts."

      Likewise for the company to do so, as we wait for an audit, apparently indefinitely.

      I
      BMXI
      Money4Nothing-M4N Money4Nothing-M4N 2 hours ago
      Definitely excited to hear about batch 5. I believe we should hear news very soon. if they began batch 5 immediately after batch 4 then 5 is overdue.

      And in light of last week's PR about Darwin's Bark Dragline silk, I'm expecting KBLB to have the attention of the DOD once again.
      KBLB
      rx7171 rx7171 2 hours ago
      Too bad no mention of the degree of brain atrophy of the Blar treated patients reverting to close to normal aging compared to the MAB treated patients having accelerated rate of atrophy.

      To me this is a bio marker that sets the two therapies at extreme ends of the plus minus continuum
      AVXL

      Your Recent History

      LSE
      0KC0
      Siauliu Bankas Ab
      AQSE
      ZGLD.GB
      ZKB Gold ETF AA CHF ETF
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads